Recommended management milestones—not external deadlines.
| Timing | Decision | Required output |
|---|---|---|
| By December 15, 2026 | Which arrangements are sufficiently evidenced to model? | Product–entity–state register and unresolved-issue list |
| Before January commitments | Which price and eligibility assumptions remain valid? | Dated quotation and programme-term refresh |
| January 2027 | Can the preferred route work in practice? | Controlled pilot with defined stop/go criteria |
| February 2027 | Is the alternative route usable? | Tested escalation and transition exercise |
| March 2027 | What should scale, change or stop? | Review of fulfilment, cost, complaints and concentration |
Bottom line: Approve a route only when the team can explain who supplies, who dispenses, who pays, what evidence supports the arrangement and how patients will be supported if it fails.
This outlook is decision support, not a legal opinion, treatment recommendation or guarantee of savings.
Explore the table row by row
A working view of the research
By December 15, 2026
- Decision
- Which arrangements are sufficiently evidenced to model?
- Required output
- Product–entity–state register and unresolved-issue list
Sources cited on this page
See the section’s source register for the research context.
Section sources →